openPR Logo
Press release

Marketing Authorisation in Europe 2009

06-17-2008 10:16 AM CET | Health & Medicine

Press release from: FORUM Institute of Management

2007/2008 have brought many changes in the field of regulatory affairs. 2009 casts its shadow ahead.
- What kind of changes does the revision of the EU guidance on the SmPC bring?
- What is the current status of the new variation regulation?
- The paperless eCTD - is it a reality coming soon?
- Sunset clause - are all questions answered?

FORUM Institute fuer Management, one of the leading professional seminar and conference providers in Europe, offers an international conference for the pharmaceutical industry on 4 September 2008 in Cologne.

Use the opportunity to speak with experts from 5 European national authorities:

- Dr. Eric Abadie, Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS), FRANCE
- Dr. Peter Bachmann, Federal Institute for Drugs and Medical Devices (BfArM), GERMANY
- Dr. Christer Backman, Medical Products Agency, SWEDEN
- Dr. Daniel Brasseur, Federal Agency for Medicines and Medicinal Products, BELGIUM
- Dr. Patrick Salmon, Irish Medicines Board, IRELAND

Further information on the conference and the company you will find under:
http://www.forum-institut.de/veranstaltung.asp?SemNr=0809235

Contact
Dr. Henriette Wolf-Klein
Department head pharma
FORUM Institut fuer Management GmbH, Heidelberg
Vangerowstraße 18
69115 Heidelberg
Tel. 0049 6221 500 680
Fax. 0049 6221 500 618
h.wolf-klein@forum-institut.de

FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CHMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Marketing Authorisation in Europe 2009 here

News-ID: 46929 • Views: 1295

More Releases from FORUM Institute of Management

Step by step through Medical Device Law
Which laws apply to a clinical trial by medical devices? Which forms of advertising are permitted? Under which circumstances is the manufacturer liable? And when is the user? The current 4th amendment of the German Medical Device Act (MPG) and the associated new requirements for manufacturers. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of discussions. FORUM Institute fuer Management,
Quality Documentation of Medicinal Substances incorporated in Medical Devices
In order to demonstrate appropriate quality for incorporated medicinal substances in medical devices (ancillary medicinal substances), applicants need to provide information and scientific data, which are similar to that requested by authorithies for API"s in medicinal products. These data are submitted to the competent authorities by the notified body involved. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of
The safety inspector for medical device
Every medical device company had to reappoint somebody to the safety inspector of medical devices. This positon comprised a great accountability with personal liability in the field of the company and also to the user. The safety inspector for medical device is bound to procedural requirements. The postion proceed an important role in the risk management. Das FORUM Institut für Management extend to this tender subject an
Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT
For the first time, all "advanced therapies" (gene therapy, somatic cell therapy and tissue engineering products) will be centralised in a single procedure of the newly adopted European Regulation No 1394/2007 ("the Regulation") on advanced therapy medicinal products (ATMPs). This regulation lays down specific rules concerning the authorisation, supervision and pharmacovigilance of ATMPs and will apply as of 30 December 2008. The focus of this seminar will be on the required legitimate

All 5 Releases


More Releases for Institut

Dentures Market Scope Assessment 2028 | Institut Straumann AG
Dentures Market: Overview Growing geriatric population drives the global dentures market across globe. Apart from this, rising dental diseases due to changing lifestyle of people also contributes to the growing dentures market. On the basis of price, the global dentures market is segmented into value dental implants, premium dental implants, and discounted dental implants. Among all, premium dental implants segment is expected to accounts for a largest share during the forecast
Toothwash Equipments Market is Thriving Worldwide | Danaher, Institut Straumann, …
HTF MI recently introduced Global Toothwash Equipments Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Danaher Corporation, Institut Straumann AG, Dentsply International, Zimmer Biomet Holdings, 3M
Cosmetics Implants Market Analysis & Forecast 2019| Dentsply Sirona, Institut St …
The research study presented here is a highly detailed and meticulous account of almost all key aspects of the global Cosmetics Implants market. It digs deep into market dynamics including growth drivers, challenges, restraints, trends, and opportunities. Market players can use the research study to tighten their grip on the global Cosmetics Implants market as they gain a sound understanding of market competition, regional growth, Cosmetics Implants market segmentation, and
Dental Implants Market Key Players - Dentsply Sirona, Institut Straumann AG, 3M, …
Market Research Future Publish a New Report on - “Dental Implants Market Research Report- Global Forecast to 2022” Exclusive Summery About Report: Dental implants are replacement of tooth roots. A dental implant is a metal post mainly made up of titanium or zirconium which is surgically positioned into the jawbone beneath the gums. Once these implants are placed into the jawbone, they allow the dentist to mount the replacement teeth over them.
Global Cosmetic Dentistry Sales Market 2017 - Danaher Corporation, Institut Stra …
The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Cosmetic Dentistry Sales industry development trends and marketing channels are analyzed. Request For Sample Report @ https://www.fiormarkets.com/report-detail/65665/request-sample The report, titled Cosmetic Dentistry Sales is an in-depth analysis of the Cosmetic Dentistry Sales market across the world. A brief historic overview of the Cosmetic Dentistry
Global Narrow Dental Implants Market 2017 : DENTATUS AB, bredent medical, Instit …
Narrow Dental Implants A market study based on the " Narrow Dental Implants Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Narrow Dental Implants Market 2017’. The research report analyses the historical as well as present performance of the worldwide Narrow Dental Implants industry, and makes predictions on the future status of Narrow Dental Implants market on the basis of this analysis. Get Free